Darwin Platform Pharmaceuticals Limited

Darwin Platform Pharmaceuticals Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85191MH2012PLC235261 Incorporated 03 September 2012 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company healthcare MSME · Small
Revenue · FY 2024
₹25.84 Cr
▲ 85.33% YoY
Net profit · FY 2024
₹57.73 Lakh
Net margin 2.2%
EBITDA · FY 2024
₹1.43 Cr
EBITDA margin 5.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹5 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
4
As per MCA filings

About Darwin Platform Pharmaceuticals Limited

Data last updated:

Darwin Platform Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 03 September 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85191MH2012PLC235261. Its GSTIN is 27AAECD3888N1ZY (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Vasu Kumar and Rahul Jeewanlal Dhote.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹25.84 Cr. For the same year it recorded a net profit of ₹57.73 Lakh (net margin 2.2%) and EBITDA of ₹1.43 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 211% over three years and 163% over five years.

As per MCA filings, the company has open charges of ₹5 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 3 cases are pending.

Darwin Platform Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0070245). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website darwinpharma.in.

Company details

CIN U85191MH2012PLC235261
Registration Number 235261
Incorporation Date 03 September 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0070245

Recognitions & Rankings of Darwin Platform Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-18-0070245

Contact details

Darwin Platform Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is darwinpharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H – Wing Unit No. 127 Ansa Industrial Estate Saki Vihar Road Saki Naka Andheri (Eas, T), Mumbai, Maharashtra, India – 400072
  • Industry
    Healthcare, Medical Consumables & Supplies

To see the full contact details of Darwin Platform Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Darwin Platform Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Darwin Platform Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Darwin Platform Pharmaceuticals Limited, buy the company report.

Financials of Darwin Platform Pharmaceuticals Limited

FY 2024 filings available

Darwin Platform Pharmaceuticals Limited reported revenue of ₹25.84 Cr for FY 2024.

Revenue · FY 2024
₹25.84 Cr
Net profit · FY 2024
₹57.73 Lakh margin 2.2%
EBITDA · FY 2024
₹1.43 Cr margin 5.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 211%
5 years · compounded
▲ 163%
EBITDA CAGR growth
3 years · compounded
▲ 159%
5 years · compounded
▲ 92%

Revenue has grown at a compounded annual rate (CAGR) of 163% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.43 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹57.73 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.5%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Darwin Platform Pharmaceuticals Limited, buy the company report.

Board of directors of Darwin Platform Pharmaceuticals Limited

Darwin Platform Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors

Peer comparison

Darwin Platform Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Servocare Lifesciences Private Limited₹25.93 Cr (FY 2024)14.0%Chandigarh, India
Asle Pharmaceuticals Private Limited₹25.9 Cr (FY 2025)7.0%Jaipur, Rajasthan, India
Keshava Medi Devices Private Limited₹25.84 Cr (FY 2025)5.0%Tirupati, Andhra Pradesh, India
Darwin Platform Pharmaceuticals Limitedthis company₹25.84 Cr (FY 2024)₹57.73 Lakh2.2%Mumbai, Maharashtra, India
Ether Pharmaceuticals Private Limited₹25.81 Cr (FY 2025)24.0%Delhi, India
Traxo Medserve Private Limited₹25.73 Cr (FY 2024)0.0%Ahmedabad, Gujarat, India
Krishaa Biotech Private Limited₹25.7 Cr (FY 2018)24.0%Kolkata, West Bengal, India

To see the full peer comparison of Darwin Platform Pharmaceuticals Limited, buy the company report.

Auditor

Darwin Platform Pharmaceuticals Limited is audited by JAIN ANIL & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
JAIN ANIL & ASSOCIATESFY 2020115987W

Shareholding

The shareholding of Darwin Platform Pharmaceuticals Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Darwin Platform Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹5 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹5.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Jun 2023100753428State Bank of India₹5 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Darwin Platform Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Darwin Platform Pharmaceuticals Limited has 1 active EPFO establishment as of Nov 16, 2026.

Active EPFO establishments
1

GST

Darwin Platform Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECD3888N1ZYMaharashtraActive13 Mar 2020

To see the full GST registrations and return filing status of Darwin Platform Pharmaceuticals Limited, buy the company report.

Recent activity

Darwin Platform Pharmaceuticals Limited has 15 board changes on record since 2012: 4 appointments and 11 cessations. The latest: Manoj Pincha was appointed as Additional Director on 10 Oct 2023.

AGM
Darwin Platform Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Darwin Platform Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Appointed
Manoj Pincha was appointed as Additional Director.
Charges
A charge with State Bank Of India amounted to Rs. 500.00 Lakh with Charge ID 100753428 was registered on 23 Jun 2023.
Ceased
Rahul Jeewanlal Dhote ceased to be Additional Director.
Ceased
Vasu Kumar ceased to be Additional Director.
Ceased
Balwant Harinath Singh ceased to be Director.
Appointed
Vasu Kumar was appointed as Director.
Ceased
Vijaypratap Ghanshyam Singh ceased to be Director.
Ceased
Harihar Ratibhan Singh ceased to be Additional Director.
Appointed
Rahul Jeewanlal Dhote was appointed as Director.
Ceased
Mohammadsalim Harun Lakhani ceased to be Additional Director.

7 earlier events are in the company report.

Frequently asked questions

Darwin Platform Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 03 September 2012 (14+ years old) and is registered under CIN U85191MH2012PLC235261.

Darwin Platform Pharmaceuticals has 4 current directors:

The latest financial statements of Darwin Platform Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Darwin Platform Pharmaceuticals is 27AAECD3888N1ZY, registered in Maharashtra.

The CIN (Corporate Identification Number) of Darwin Platform Pharmaceuticals is U85191MH2012PLC235261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Darwin Platform Pharmaceuticals has 5 court cases on record: 1 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.

Darwin Platform Pharmaceuticals was incorporated on 03 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Darwin Platform Pharmaceuticals by revenue are Servocare Lifesciences Private Limited, Asle Pharmaceuticals Private Limited, Keshava Medi Devices Private Limited, Ether Pharmaceuticals Private Limited, Traxo Medserve Private Limited and 1 more, all in the Healthcare industry (Medical Consumables, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Manoj Pincha was appointed as Additional Director on 10 Oct 2023. Rahul Jeewanlal Dhote ceased to be Additional Director on 30 Nov 2021. Vasu Kumar ceased to be Additional Director on 30 Nov 2021. Darwin Platform Pharmaceuticals has 15 board changes on record in total.

Yes, Darwin Platform Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0070245).

Darwin Platform Pharmaceuticals can be reached through the website darwinpharma.in. Its registered office is in Mumbai, Maharashtra, India.